-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DQiLtgEmHU43t8n0B6gcWgHiP3I8tM4PtDkBs5k6FMvbPwuFem6FT6YH7pHDY+UM aTaunzkFfH92W9O5lgPmhg== 0001140361-10-011227.txt : 20100310 0001140361-10-011227.hdr.sgml : 20100310 20100310181921 ACCESSION NUMBER: 0001140361-10-011227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100303 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEISER MICHAEL CENTRAL INDEX KEY: 0001221449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 10671800 MAIL ADDRESS: STREET 1: 130 EAST 75TH ST STREET 2: APT 6B CITY: NEW YORK STATE: NY ZIP: 10021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 doc1.xml FORM 4 X0303 4 2010-03-03 1 0001001316 MANHATTAN PHARMACEUTICALS INC MHAN 0001221449 WEISER MICHAEL C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET, SUITE 1110 NEW YORK NY 10005 0 0 0 1 Former Director Common Stock 2010-03-08 4 J 0 44678 A 2292241 D Stock Options 1.65 2014-01-27 Common Stock 75000 75000 D Warrant 1.44 2010-08-30 Common Stock 24099 24099 D Stock Options 1.00 2015-01-11 Common Stock 30000 30000 D Stock Options 0.71 2017-01-30 Common Stock 50000 50000 D Stock Options 0.17 2018-03-25 Common Stock 75000 75000 D Warrant 0.20 2013-09-10 Common Stock 24000 24000 D Stock Options 0.07 2010-03-03 4 A 0 250000 0 A 2015-03-02 Common Stock 250000 250000 D Received in exchange for 117,342 shares of common stock of Ariston Pharmaceuticals, Inc. ("Ariston") in connection with the merger (the "Ariston Merger") of Ariston with a wholly-owned subsidiary of Manhattan Pharmaceuticals, Inc. (the "Company"). On the effective date of the Ariston Merger, the closing price of the Company's common stock ("Common Stock") was $0.065 per share, and there was no market price for Ariston's common stock because Ariston was a private company. The option has vested in its entirety. The warrants are exercisable immediately. The option has vested in its entirety. The option has vested in its entirety. The option vested as to 41,667 shares on March 25, 2008 and as to an additional 16,667 shares on March 25, 2009. The remaining 16,666 shares are scheduled to vest on March 25, 2010. On March 3, 2010, the reporting person was granted an option to purchase 250,000 shares of Common Stock under the 2003 Stock Option Plan. The reporting person left the Company's board of directors on March 8, 2010. The option vested in its entirety on the date of grant. /s/ Michael Weiser 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----